MA, BM, BCh, DM, MRCP, FRCOphth, FRANZCO, FARVO, FAAPPO, ALCM
Professor Keith Martin is Managing Director of the Centre for Eye Research Australia (CERA) and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne.
He is also Honorary Senior Research Fellow at the University of Cambridge, Honorary Professor of Ophthalmology at the University of Sydney and a Senior Visiting Medical Officer for the Glaucoma Unit at Royal Victorian Eye and Ear Hospital. Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma. He is immediate Past President of the World Glaucoma Association (WGA), the largest glaucoma organisation in the world, and remains a Governor of WGA. He is President of the Australia and New Zealand Glaucoma Society.
Professor Martin is working to develop new treatments for eye disease using stem cells, gene therapy and other techniques as a Principal Investigator at CERA. He is co-founder of Quethera, a Cambridge-based gene therapy company which has developed a gene therapy for glaucoma that is currently progressing towards human clinical trials. He is also co-founder of Ikarovec, a second gene therapy spin out company from his lab developing gene therapies for common retinal diseases, and a Director of Enlighten Imaging, a CERA spin-out company.
Read More